|
Q2 FY2026
As of Jun 28, 2026
|
Q1 FY2026
As of Mar 29, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 28, 2025
|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 29, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 1, 2023
|
Q2 FY2023
As of Jul 2, 2023
|
Q1 FY2023
As of Apr 2, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 2, 2022
|
Q2 FY2022
As of Jul 3, 2022
|
Q1 FY2022
As of Apr 3, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Oct 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term deposits | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $6,553 and $6,366 respectively | ||||||||||||||||||||
| Identified intangible assets, net of accumulated amortization of $812 and $820 respectively | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Restructuring liabilities-current | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities: | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Restructuring liabilities | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity: | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, par value €0.20 per share: | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Treasury shares, at cost: | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Preferred stock, par value per share (in euros per share) | ||||||||||||||||||||
| Preferred stock, authorized shares (in shares) | ||||||||||||||||||||
| Preferred stock, issued (in shares) | ||||||||||||||||||||
| Common Stock, authorized shares (in shares) | ||||||||||||||||||||
| Common stock, issued and fully paid (in shares) | ||||||||||||||||||||
| Treasury shares (in shares) |
Loading...